CCO Oncology Podcast
Een podcast door Clinical Care Options
189 Afleveringen
-
Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions
Gepubliceerd: 31-1-2022 -
Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease
Gepubliceerd: 26-1-2022 -
Experts Answer Questions on Current and Emerging Options for Hemophilia A Management
Gepubliceerd: 14-1-2022 -
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
Gepubliceerd: 10-1-2022 -
Strategies for Secondary AML and Emerging Therapies for AML
Gepubliceerd: 10-1-2022 -
Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
Gepubliceerd: 10-1-2022 -
An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy
Gepubliceerd: 10-1-2022 -
Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications
Gepubliceerd: 22-12-2021 -
Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications
Gepubliceerd: 22-12-2021 -
Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
Gepubliceerd: 17-12-2021 -
The Evolving Role of TKIs in First-line Treatment of Advanced HCC
Gepubliceerd: 14-12-2021 -
Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers
Gepubliceerd: 23-11-2021 -
Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer
Gepubliceerd: 23-11-2021 -
Overcoming Acquired Resistance With Second-Generation TRK Inhibitors
Gepubliceerd: 9-11-2021 -
Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma
Gepubliceerd: 2-11-2021 -
PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape
Gepubliceerd: 26-10-2021 -
Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
Gepubliceerd: 21-10-2021 -
First-Generation TRK Inhibitors: Clinical Evidence and Indications
Gepubliceerd: 15-10-2021 -
PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm
Gepubliceerd: 14-10-2021 -
Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A
Gepubliceerd: 8-10-2021
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
